Physical Activity After Cancer Diagnosis Improves Survival
Findings seen among postmenopausal breast cancer patients regardless of activity level prediagnosis.
Breast Cancer
FDA Proposal Threatens Transparency on Cancer Drug Safety and Efficacy
FDA documents have been a trove of information for researchers, leading to new insights about the safety and efficacy of a drug. An FDA proposal could end that.
Cancer Screening Rates Lower Among Women With Diabetes
Rates for breast, cervical, colorectal cancer screening lower compared with women without diabetes.
Patient Simulation Project in Lung, Breast Cancers Points to Improvements in Quality of Care
Palliative care and end-of-life needs were not addressed for approximately 40% of simulated patients who would have been eligible for this approach.
Prediagnosis Exercise May Reduce CV Risk in Breast Cancer
Incidence of composite cardiovascular events decreased across increasing total MET hours/week.
Sensitive ctDNA Test Predicts Residual Breast Cancer Following Neoadjuvant Therapy
If validated, a patient-specific ctDNA assay for residual disease after neoadjuvant therapy could bring an end to the surgery-for-all approach in breast cancer.
Everyone’s Conflicted: How Open Payments Did Little to Discourage Conflicts of Interest in Oncology
Since its inception, the Open Payments act does not appear to have prompted physicians to accept fewer payments from industry overall.
The Disappointing Reality of Crowdfunding Cancer Care
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.
CDK4/6 Inhibitor + AI Therapy is Effective in Both Older and Younger Women With Breast Cancer
Rates of grade 3/4 AEs and dose reductions/interruptions associated with CDK4/6 + AI therapy were higher in those 75 years and older compared with younger patients.
Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
Next post in General Oncology
